{"entity":{"type":"insider","cik":"0001741533","url":"/insider/0001741533","json_url":"/insider/0001741533.json","name":"Paolini John F.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":15,"first":"2020-02-18","last":"2026-05-05","span_basis":"filed_date"},"name_variants":[{"name":"Paolini John F.","source":"filing","n_filings":15,"first_seen":"2020-02-18","last_seen":"2026-05-05"}],"transactions":[{"id":6158781,"accession":"0001741533-26-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001741533-26-000008","line_url":"/filing/0001741533-26-000008","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58424.0,"shares_display":"58,424","price_per_share":53.707772833082295,"price_display":"53.71","price_state":"stated","total_value":3137822.92,"total_display":"3,137,822.92","total_whole":"3,137,823","shares_owned_after":86720.0,"shares_owned_after_display":"86,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-05","scope":"insider","n_lines":2},{"id":6061180,"accession":"0001741533-26-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001741533-26-000002","line_url":"/filing/0001741533-26-000002","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":44.823493,"price_display":"44.82","price_state":"stated","total_value":1792939.72,"total_display":"1,792,939.72","total_whole":"1,792,940","shares_owned_after":67038.0,"shares_owned_after_display":"67,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":3},{"id":4637646,"accession":"0001741533-25-000003","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001741533-25-000003","line_url":"/filing/0001741533-25-000003#line-3","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82542.0,"shares_display":"82,542","price_per_share":37.14,"price_display":"37.14","price_state":"stated","total_value":3065609.88,"total_display":"3,065,609.88","total_whole":"3,065,610","shares_owned_after":61324.0,"shares_owned_after_display":"61,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-31","filed_date":"2025-11-04","scope":"insider"},{"id":4708874,"accession":"0001415889-25-021346","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-021346","line_url":"/filing/0001415889-25-021346#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29325.0,"shares_display":"29,325","price_per_share":32.55,"price_display":"32.55","price_state":"stated","total_value":954528.75,"total_display":"954,528.75","total_whole":"954,529","shares_owned_after":57403.0,"shares_owned_after_display":"57,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-06","filed_date":"2025-08-08","scope":"insider"},{"id":5193742,"accession":"0001415889-25-012541","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-012541","line_url":"/filing/0001415889-25-012541#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":57403.0,"shares_owned_after_display":"57,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-07","filed_date":"2025-05-09","scope":"insider"},{"id":2863715,"accession":"0001415889-24-022856","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001415889-24-022856","line_url":"/filing/0001415889-24-022856","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60692.0,"shares_display":"60,692","price_per_share":26.115326566928097,"price_display":"26.12","price_state":"stated","total_value":1584991.4,"total_display":"1,584,991.40","total_whole":"1,584,991","shares_owned_after":53516.0,"shares_owned_after_display":"53,516","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-04","scope":"insider","n_lines":2},{"id":2448266,"accession":"0001415889-24-020104","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-020104","line_url":"/filing/0001415889-24-020104","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals International, plc","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Ordinary Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000.0,"shares_display":"22,000","price_per_share":26.31664272727273,"price_display":"26.32","price_state":"stated","total_value":578966.14,"total_display":"578,966.14","total_whole":"578,966","shares_owned_after":47903.0,"shares_owned_after_display":"47,903","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-23","filed_date":"2024-07-25","scope":"insider","n_lines":4},{"id":2369288,"accession":"0001415889-24-006674","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-006674","line_url":"/filing/0001415889-24-006674#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18844.0,"shares_display":"18,844","price_per_share":21.77,"price_display":"21.77","price_state":"stated","total_value":410233.88,"total_display":"410,233.88","total_whole":"410,234","shares_owned_after":44892.0,"shares_owned_after_display":"44,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-05","scope":"insider"},{"id":2562820,"accession":"0001415889-24-005883","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-005883","line_url":"/filing/0001415889-24-005883#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10156.0,"shares_display":"10,156","price_per_share":21.03,"price_display":"21.03","price_state":"stated","total_value":213580.68,"total_display":"213,580.68","total_whole":"213,581","shares_owned_after":44892.0,"shares_owned_after_display":"44,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-29","scope":"insider"},{"id":7959285,"accession":"0001415889-23-016183","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-23-016183","line_url":"/filing/0001415889-23-016183","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28600.0,"shares_display":"28,600","price_per_share":17.648894755244754,"price_display":"17.65","price_state":"stated","total_value":504758.39,"total_display":"504,758.39","total_whole":"504,758","shares_owned_after":53095.0,"shares_owned_after_display":"53,095","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-07","filed_date":"2023-12-11","scope":"insider","n_lines":4},{"id":8479967,"accession":"0001415889-23-013038","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001415889-23-013038","line_url":"/filing/0001415889-23-013038#line-6","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":17.53,"price_display":"17.53","price_state":"stated","total_value":7012.0,"total_display":"7,012.00","total_whole":"7,012","shares_owned_after":44892.0,"shares_owned_after_display":"44,892","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-06","scope":"insider"},{"id":8763929,"accession":"0001415889-23-011525","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-23-011525","line_url":"/filing/0001415889-23-011525","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":19.14345103448276,"price_display":"19.14","price_state":"stated","total_value":555160.08,"total_display":"555,160.08","total_whole":"555,160","shares_owned_after":49542.0,"shares_owned_after_display":"49,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-25","filed_date":"2023-07-27","scope":"insider","n_lines":3},{"id":6968803,"accession":"0001415889-22-011237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-22-011237","line_url":"/filing/0001415889-22-011237#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Class A Common Share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28357.0,"shares_display":"28,357","price_per_share":15.18,"price_display":"15.18","price_state":"stated","total_value":430459.26,"total_display":"430,459.26","total_whole":"430,459","shares_owned_after":36335.0,"shares_owned_after_display":"36,335","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-07","filed_date":"2022-11-09","scope":"insider"},{"id":3336716,"accession":"0001179110-20-002033","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-20-002033","line_url":"/filing/0001179110-20-002033","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9803.0,"shares_display":"9,803","price_per_share":18.956675507497703,"price_display":"18.96","price_state":"stated","total_value":185832.29,"total_display":"185,832.29","total_whole":"185,832","shares_owned_after":19116.0,"shares_owned_after_display":"19,116","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-20","filed_date":"2020-02-21","scope":"insider","n_lines":2},{"id":3336708,"accession":"0001179110-20-002033","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-002033","line_url":"/filing/0001179110-20-002033#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22477.0,"shares_display":"22,477","price_per_share":18.27,"price_display":"18.27","price_state":"stated","total_value":410654.79,"total_display":"410,654.79","total_whole":"410,655","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-19","filed_date":"2020-02-21","scope":"insider"},{"id":2088069,"accession":"0001179110-20-001763","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-20-001763","line_url":"/filing/0001179110-20-001763#line-4","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1039.0,"shares_display":"1,039","price_per_share":18.33,"price_display":"18.33","price_state":"stated","total_value":19044.87,"total_display":"19,044.87","total_whole":"19,045","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-18","scope":"insider"},{"id":2088067,"accession":"0001179110-20-001763","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-001763","line_url":"/filing/0001179110-20-001763#line-2","is_derivative":false,"issuer_cik":"0001730430","issuer_name":"Kiniksa Pharmaceuticals, Ltd.","issuer_ticker":"KNSA","issuer_name_source":null,"issuer_url":"/issuer/0001730430","owner_cik":"0001741533","owner_name":"Paolini John F.","owner_display_name":"Paolini John F.","owner_url":"/insider/0001741533","role":"Officer (SVP & Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP & Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & Chief Medical Officer","security_title":"Class A Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10277.0,"shares_display":"10,277","price_per_share":18.29,"price_display":"18.29","price_state":"stated","total_value":187966.33,"total_display":"187,966.33","total_whole":"187,966","shares_owned_after":18000.0,"shares_owned_after_display":"18,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-13","filed_date":"2020-02-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001730430","name":"Kiniksa Pharmaceuticals International, plc","url":"/issuer/0001730430","role":"Officer (CHIEF MEDICAL OFFICER)","n_filings":15,"first_seen":"2020-02-18","last_seen":"2026-05-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001741533","retrieved_at":"2026-08-23T03:15:23+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}